%0 Journal Article
%T Factors that Predict Clinical Benefit of EGFR TKI Therapy in Patients with EGFR Wild-Type Lung Adenocarcinoma
%A Cheol Hyeon Kim
%A Hee Jong Baek
%A Hye-Ryoun Kim
%A Im Il Na
%A Jae Kyung Myung
%A Jae Soo Koh
%A Seo Yun Kim
%J Archive of "Tuberculosis and Respiratory Diseases".
%D 2019
%R 10.4046/trd.2018.0004
%K Adenocarcinoma
%K Receptor
%K Epidermal Growth Factor
%K Lung Neoplasms
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304331/